EDGAR Verified
Primary Source · SEC.gov

Sky Life Sciences Fund, LP

CIK 0002062671Fund Vehicle2026 vintage506(b), 3(c)(1)

Raised

$62M

Investors

10

Min Invest

$0

AltStreet Analysis

·

Generated from EDGAR primary sources

Sky Life Sciences Fund, LP is a Delaware limited partnership that has raised $62.1M from 10 investors under Rule 506(b) and Section 3(c)(1). This amended filing, filed March 3, 2026, lists Benny Soffer as Executive Officer and Promoter. The fund operates in the longevity biotech category as a pooled investment vehicle.

This longevity biotech fund follows the conventional private fund structure using 506(b) and 3(c)(1) exemptions, typical for institutional life sciences vehicles. With $62.1M raised from 10 investors, the average commitment of approximately $6.2M per investor suggests accredited or qualified purchaser participation consistent with biotech venture funds.

Data Flags

first_sale_dateFirst sale date not disclosed on an amended filing with $62.1M already raised; unusual for sub-$100M fund amendments to omit this date
generalAmendment filing with material capital raised but no prior EDGAR history visible for this CIK; may be first public disclosure of previously unreported sales

EDGAR Filing Data

Form D — Primary Source

View on SEC.gov
CIK Number0002062671
Entity NameSky Life Sciences Fund, LP
Exemption506(b), 3(c)(1)
First Sale Date
Filing DateMarch 3, 2026
Accession Number0002062671-26-000001
Total Amount Sold$62M
Total Investors10
Minimum Investment$0 (no stated minimum)
Securities TypeEquity, Pooled Investment Fund
State of IncorporationNot specified
Amendment CountOriginal filing only

Related Persons (Form D)

Executive officers, directors, and promoters listed on the SEC Form D filing. Source: SEC.gov.

Benny Soffer

Executive Officer, Promoter · Princeton, NJ

Is this your offering?

Claim this profile to add contact information, team members, LinkedIn profiles, fund history, and additional financial data. EDGAR-sourced data and AltStreet analysis cannot be edited, but corrections can be requested for verifiable inaccuracies.

Data Methodology

Capital raise figures, investor counts, and filing dates are sourced directly from SEC EDGAR Form D primary documents via the SEC EDGAR submissions API and full-text search index. EDGAR entity profiles and deal-level data are reviewed by AltStreet analysts with backgrounds in corporate finance and securities law — cross-referenced against offering circulars, audited financial statements, and primary regulatory filings before publication. Platform-provided information, where present, is clearly labeled and does not affect EDGAR data or AltStreet editorial coverage. Platforms may request factual corrections for demonstrable inaccuracies by contacting [email protected]. This page does not constitute investment advice.